BIOBRIEF Trademark

Trademark Overview


On Thursday, August 7, 2025, a trademark application was filed for BIOBRIEF with the United States Patent and Trademark Office. The USPTO has given the BIOBRIEF trademark a serial number of 99325151. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, January 1, 2026. This trademark is owned by GATC Health Corp. The BIOBRIEF trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Testing of pharmaceuticals; Research on the subject of pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Technical consulting in the field of pharmaceutical studies; Consulting services in the field of pharmaceutical research; Research and development services of new pharmaceutical products; Technical research in the field of pharmaceutical studies; Research and development in the pharmaceutical and biotechnology fields; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Consulting services in the field of pharmaceutical research and development; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Medical and pharmaceutical consultation
biobrief

General Information


Serial Number99325151
Word MarkBIOBRIEF
Filing DateThursday, August 7, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, January 1, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 20, 2026

Trademark Statements


Goods and ServicesTesting of pharmaceuticals; Research on the subject of pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Technical consulting in the field of pharmaceutical studies; Consulting services in the field of pharmaceutical research; Research and development services of new pharmaceutical products; Technical research in the field of pharmaceutical studies; Research and development in the pharmaceutical and biotechnology fields; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Consulting services in the field of pharmaceutical research and development; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Goods and ServicesMedical and pharmaceutical consultation
Pseudo MarkBIO BRIEF

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 7, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 7, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGATC Health Corp
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614

Trademark Events


Event DateEvent Description
Thursday, August 7, 2025NEW APPLICATION ENTERED
Thursday, August 7, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, December 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, December 21, 2025ASSIGNED TO EXAMINER
Tuesday, December 23, 2025APPROVED FOR PUB - PRINCIPAL REGISTER